Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34295687/

In oncogene-addicted NSCLC (with the exception of KRAS -mutated), ICIs are usually administered at the failure of other treatment options, but administering single-agent immunotherapy in later disease phases may limit its efficacy. With the progressive administration of TKIs and ICIs in early- ...